Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicin

Peng,Wanxin; Du,Tong; Zhang,Zihao; Du,Fengyi; Jin,Jie; Gong,Aihua

doi:10.3892/etm.2015.2266

Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicin

Authors:
- Wanxin Peng
- Tong Du
- Zihao Zhang
- Fengyi Du
- Jie Jin
- Aihua Gong
View Affiliations

Affiliations: School of Medical Sciences and Laboratory Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China
Published online on: February 5, 2015 https://doi.org/10.3892/etm.2015.2266
Pages: 1271-1276

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is a major public health problem. Despite new chemotherapeutic treatments, drug resistance remains a major clinical obstacle to successful treatment in HCC patients. Therefore, novel therapeutic targets and new modalities of treatment are urgently required. In this study, tetracycline‑inducible lentivirus‑mediated RNA interference (RNAi) was employed to knock down microtubule‑associated protein 1 light chain 3 (LC3) gene, which encodes a key protein in the induction of autophagy, to study the protective function of autophagy in liver cancer tolerant to epirubicin. The effect of combined treatment with lentiviral shLC3 and epirubicin on cell growth and chemosensitivity to epirubicin in the HCC cell line HepG2 were also investigated. The results demonstrated that lentivirus‑mediated LC3 silencing significantly inhibited cell proliferation. In addition, combined treatment with lentiviral shLC3 and epirubicin significantly decreased the survival rate of HepG2 cells, compared with that following treatment with either agent alone. Overall, the results from this study suggest for the first time, to the best of our knowledge, that LC3 plays a key role in HCC tumorigenesis, and is a novel therapeutic target for HCC.

View Figures

View References

1	Ding J and Wang H: Multiple interactive factors in hepatocarcinogenesis. Cancer Lett. 346:17–23. 2014. View Article : Google Scholar : PubMed/NCBI
2	Li J, Lau GK, Chen L, Dong SS, Lan HY, et al: Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-κB induced matrix metalloproteinases 2 and 9 expression. PloS One. 6:e218162011. View Article : Google Scholar
3	Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science. 290:1717–1721. 2000. View Article : Google Scholar : PubMed/NCBI
4	Yoshimori T: Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun. 313:453–458. 2004. View Article : Google Scholar
5	Tanida I, Ueno T and Kominami E: LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 36:2503–2518. 2004. View Article : Google Scholar : PubMed/NCBI
6	Okamoto K, Kondo-Okamoto N and Ohsumi Y: Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev Cell. 17:87–97. 2009. View Article : Google Scholar : PubMed/NCBI
7	Reggiori F and Klionsky DJ: Autophagy in the eukaryotic cell. Eukaryotic Cell. 1:11–21. 2002. View Article : Google Scholar : PubMed/NCBI
8	Turcotte S and Giaccia AJ: Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol. 22:246–251. 2010. View Article : Google Scholar : PubMed/NCBI
9	Hollomon MG, Gordon N, Santiago-O’Farrill JM and Kleinerman ES: Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells. BMC Cancer. 13:5002013. View Article : Google Scholar : PubMed/NCBI
10	Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, et al: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
11	Feng Z: p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol. 2:a0010572010. View Article : Google Scholar : PubMed/NCBI
12	Notte A, Leclere L and Michiels C: Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem Pharmacol. 82:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
13	Huang G, Jiang QH, Cai C, Qu M and Shen W: SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway. Cancer Lett. Dec 17–2014.(Epub ahead of print).
14	Tian Y, Kuo C, Sir D, et al: Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis. Cell Death Differ. Dec 19–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
15	Pan H, Wang Z, Jiang L, et al: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib. Sci Rep. 4:66832014. View Article : Google Scholar : PubMed/NCBI
16	Shi YH, Ding ZB, Zhou J, et al: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy. 7:1159–1172. 2011. View Article : Google Scholar : PubMed/NCBI
17	Wiederschain D, Wee S, Chen L, Loo A, Yang GZ, et al: Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle. 8:498–504. 2009. View Article : Google Scholar : PubMed/NCBI
18	Paglin S, Hollister T, Delohery T, et al: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
19	Yamamoto Y, Mochida J, Sakai D, et al: Upregulation of the viability of nucleus pulposus cells by bone marrow-derived stromal cells: significance of direct cell-to-cell contact in coculture system. Spine (Phila Pa 1976). 29:1508–1514. 2004. View Article : Google Scholar
20	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
21	Chen L, Ye HL, Zhang G, Yao WM, Chen XZ, et al: Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells. PloS One. 9:e857712014. View Article : Google Scholar : PubMed/NCBI
22	Alberti A, Clumeck N, Collins S, et al; ECC Jury. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol. 42:615–624. 2005. View Article : Google Scholar : PubMed/NCBI
23	Chen J, Ding Z, Peng Y, et al: HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein. PLoS One. 9:e988822014. View Article : Google Scholar
24	Tao W, Shi JF, Zhang Q, Xue B, Sun YJ and Li CJ: Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner. Biomed Pharmacother. 67:197–202. 2013. View Article : Google Scholar : PubMed/NCBI
25	Zhou Y, Sun K, Ma Y, et al: Autophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells. Sci Rep. 4:53822014.PubMed/NCBI
26	Meijer AJ and Codogno P: Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol. 36:2445–2462. 2004. View Article : Google Scholar : PubMed/NCBI
27	Li L, Liu GD, Zhang XJ and Li YB: Autophagy, a novel target for chemotherapeutic intervention of thyroid cancer. Cancer Chemother Pharmacol. 73:439–449. 2014. View Article : Google Scholar
28	Tanida I, Minematsu-Ikeguchi N, Ueno T and Kominami E: Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 1:84–91. 2005. View Article : Google Scholar
29	Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
30	Mizushima N and Levine B: Autophagy in mammalian development and differentiation. Nat Cell Biol. 12:823–830. 2010. View Article : Google Scholar : PubMed/NCBI
31	White E, Karp C, Strohecker AM, et al: Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 22:212–217. 2010. View Article : Google Scholar : PubMed/NCBI
32	Sui XB, Kong N, Ye L, Han W, Zhou J, et al: p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 344:174–179. 2014. View Article : Google Scholar
33	Ge YY, Shi Q, Zheng ZY, et al: MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R. Oncotarget. 5:6218–6228. 2014.PubMed/NCBI
34	Yuan H, Li AJ, Ma SL, et al: Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells. World J Gastroenterol. 20:4953–4962. 2014. View Article : Google Scholar : PubMed/NCBI
35	Cao H, Phan H and Yang LX: Improved chemotherapy for hepatocellular carcinoma. Anticancer Res. 32:1379–1386. 2012.PubMed/NCBI